Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.

PHASE4CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

September 30, 2014

Conditions
ST-Segment Elevation Myocardial Infarction
Interventions
DRUG

Ezetimibe

100 patients with ST elevation myocardial infarction are randomized 1:1 to either placebo or Ezetimibe 10 mg per day in addition to treatment with Atorvastatin 80 mg in both arms.

DRUG

Placebo

100 patients with ST elevation myocardial infarction are randomized 1:1 to either placebo or Ezetimibe 10 mg per day in addition to treatment with Atorvastatin 80 mg in both arms.

Trial Locations (1)

5000

Department of Cardiology, Odense University Hospital, Odense C

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT01385631 - Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction. | Biotech Hunter | Biotech Hunter